BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shamsi K, Balzer T, Saini S, Ros PR, Nelson RC, Carter EC, Tollerfield S, Niendorf HP. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging. Radiology. 1998;206:365-371. [PMID: 9457187 DOI: 10.1148/radiology.206.2.9457187] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Tanimoto A, Kadoya M, Kawamura Y, Kuwatsuru R, Gokan T, Hirohashi S. Safety and efficacy of a novel hepatobiliary MR contrast agent, Gd-DTPA-DeA: Results of phase I and phase II clinical trials. J Magn Reson Imaging 2006;23:499-508. [DOI: 10.1002/jmri.20543] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Xu J, Yu M, Peng C, Carter P, Tian J, Ning X, Zhou Q, Tu Q, Zhang G, Dao A, Jiang X, Kapur P, Hsieh JT, Zhao X, Liu P, Zheng J. Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates. Angew Chem Int Ed Engl 2018;57:266-71. [PMID: 29160029 DOI: 10.1002/anie.201710584] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
3 Xu J, Yu M, Peng C, Carter P, Tian J, Ning X, Zhou Q, Tu Q, Zhang G, Dao A, Jiang X, Kapur P, Hsieh J, Zhao X, Liu P, Zheng J. Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates. Angew Chem 2018;130:272-7. [DOI: 10.1002/ange.201710584] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
4 Cheng Z, Yan X, Sun X, Shen B, Gambhir SS. Tumor Molecular Imaging with Nanoparticles. Engineering 2016;2:132-40. [DOI: 10.1016/j.eng.2016.01.027] [Cited by in Crossref: 21] [Article Influence: 3.5] [Reference Citation Analysis]
5 Earls JP, Bluemke DA. NEW MR IMAGING CONTRAST AGENTS. Magnetic Resonance Imaging Clinics of North America 1999;7:255-73. [DOI: 10.1016/s1064-9689(21)00021-0] [Cited by in Crossref: 20] [Article Influence: 0.9] [Reference Citation Analysis]
6 Zhang Y, Yang Y, Cai W. Multimodality Imaging of Integrin α(v)β(3) Expression. Theranostics 2011;1:135-48. [PMID: 21547156 DOI: 10.7150/thno/v01p0135] [Cited by in Crossref: 30] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
7 Park JA, Kim HK, Kim JH, Jeong SW, Jung JC, Lee GH, Lee J, Chang Y, Kim TJ. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett 2010;20:2287-91. [PMID: 20188545 DOI: 10.1016/j.bmcl.2010.02.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
8 Wang P, Toledo D, Zhang E, Telusma M, Mcdaniel D, Liang P, Khizroev S. Scanning probe microscopy study of cobalt ferrite-barium titanate coreshell magnetoelectric nanoparticles. Journal of Magnetism and Magnetic Materials 2020;516:167329. [DOI: 10.1016/j.jmmm.2020.167329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 von Falkenhausen M, Meyer C, Lutterbey G, Morakkabati N, Walter O, Gieseke J, Blömer R, Willinek WA, Kuhl CK, Schild HH. Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. Eur Radiol 2007;17:1256-61. [PMID: 17171512 DOI: 10.1007/s00330-006-0484-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
10 Heidt T, Nahrendorf M. Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed 2013;26:756-65. [PMID: 23065771 DOI: 10.1002/nbm.2872] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
11 Siglienti I, Bendszus M, Kleinschnitz C, Stoll G. Cytokine profile of iron-laden macrophages: implications for cellular magnetic resonance imaging. J Neuroimmunol 2006;173:166-73. [PMID: 16380168 DOI: 10.1016/j.jneuroim.2005.11.011] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 3.8] [Reference Citation Analysis]
12 Chen F, Ward J, Robinson P. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents. Magnetic Resonance Imaging 1999;17:549-56. [DOI: 10.1016/s0730-725x(98)00193-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
13 Kaim AH, Wischer T, O’reilly T, Jundt G, Fröhlich J, von Schulthess GK, Allegrini PR. MR Imaging with Ultrasmall Superparamagnetic Iron Oxide Particles in Experimental Soft-Tissue Infections in Rats. Radiology 2002;225:808-14. [DOI: 10.1148/radiol.2253011485] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 3.0] [Reference Citation Analysis]
14 Do MA, Yoon GJ, Yeum JH, Han M, Chang Y, Choi JH. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T 2 magnetic resonance imaging. Colloids and Surfaces B: Biointerfaces 2014;122:752-9. [DOI: 10.1016/j.colsurfb.2014.08.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
15 Kim HJ, Kim KW, Byun JH, Won HJ, Shin YM, Kim PN, Lee MS, Lee MG. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. AJR Am J Roentgenol. 2006;186:1059-1066. [PMID: 16554579 DOI: 10.2214/ajr.04.1941] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kim MJ, Kim JH, Choi JY, Park SH, Chung JJ, Kim KW, Mitchell DG. Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions. AJR Am J Roentgenol 2006;187:W255-66. [PMID: 16928903 DOI: 10.2214/AJR.05.0706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Pan D, Lanza GM, Wickline SA, Caruthers SD. Nanomedicine: perspective and promises with ligand-directed molecular imaging. Eur J Radiol 2009;70:274-85. [PMID: 19268515 DOI: 10.1016/j.ejrad.2009.01.042] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
18 Kehagias DT, Gouliamos AD, Smyrniotis V, Vlahos LJ. Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595-601. [DOI: 10.1002/jmri.1224] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
19 Moghadam FF. Using Nanoparticles in Medicine for Liver Cancer Imaging. Oman Med J 2017;32:269-74. [PMID: 28804578 DOI: 10.5001/omj.2017.54] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shiratori Y, Yoshida H, Omata M. Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention. Expert Rev Anticancer Ther. 2001;1:277-290. [PMID: 12113033 DOI: 10.1586/14737140.1.2.277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
21 Kondo H, Kanematsu M, Hoshi H, Murakami T, Kim T, Hori M, Matsuo M, Nakamura H. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR Am J Roentgenol. 2000;174:947-954. [PMID: 10749228 DOI: 10.2214/ajr.174.4.1740947] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
22 Kim SH, Choi D, Lim HK, Kim MJ, Jang KM, Kim SH, Lee WJ, Lee J, Jeon YH, Lim JH. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences. European Journal of Radiology 2006;59:413-23. [DOI: 10.1016/j.ejrad.2006.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
23 Thorek DLJ, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging. Ann Biomed Eng 2006;34:23-38. [DOI: 10.1007/s10439-005-9002-7] [Cited by in Crossref: 537] [Cited by in F6Publishing: 461] [Article Influence: 33.6] [Reference Citation Analysis]
24 Bendszus M, Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J Neurosci 2003;23:10892-6. [PMID: 14645484 [PMID: 14645484 DOI: 10.1523/jneurosci.23-34-10892.2003] [Cited by in Crossref: 115] [Article Influence: 6.1] [Reference Citation Analysis]
25 Schnorr J, Taupitz M, Wagner S, Pilgrimm H, Hansel J, Hamm B. Age-related blood half-life of particulate contrast material: experimental results with a USPIO in rats. J Magn Reson Imaging 2000;12:740-4. [PMID: 11050644 DOI: 10.1002/1522-2586(200011)12:5<740::aid-jmri11>3.0.co;2-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, Kako N, Matsunaga N, Hoshi H, Shiraishi J. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging. AJR Am J Roentgenol. 2001;177:637-643. [PMID: 11517061 DOI: 10.2214/ajr.177.3.1770637] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
27 Reddy LH, Arias JL, Nicolas J, Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012;112:5818-78. [PMID: 23043508 DOI: 10.1021/cr300068p] [Cited by in Crossref: 1330] [Cited by in F6Publishing: 1001] [Article Influence: 133.0] [Reference Citation Analysis]
28 Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-specific MR contrast agents. Eur J Radiol 2003;46:33-44. [PMID: 12648800 DOI: 10.1016/s0720-048x(02)00332-7] [Cited by in Crossref: 192] [Cited by in F6Publishing: 31] [Article Influence: 10.1] [Reference Citation Analysis]
29 Hao R, Xing R, Xu Z, Hou Y, Gao S, Sun S. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Adv Mater 2010;22:2729-42. [DOI: 10.1002/adma.201000260] [Cited by in Crossref: 1076] [Cited by in F6Publishing: 860] [Article Influence: 89.7] [Reference Citation Analysis]
30 Kamel IR, Bluemke DA. MR imaging of liver tumors. Radiologic Clinics of North America 2003;41:51-65. [DOI: 10.1016/s0033-8389(02)00067-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
31 Cai W, Chen X. Nanoplatforms for Targeted Molecular Imaging in Living Subjects. Small 2007;3:1840-54. [DOI: 10.1002/smll.200700351] [Cited by in Crossref: 403] [Cited by in F6Publishing: 353] [Article Influence: 26.9] [Reference Citation Analysis]
32 Wang Q, Su H, Xia C, Sun J, Liu C, Wang Z, Gong Q, Song B, Gao F, Ai H, Gu Z. Amphiphilic dextran/magnetite nanocomposites as magnetic resonance imaging probes. Chin Sci Bull 2009;54:2925-33. [DOI: 10.1007/s11434-009-0255-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
33 Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Gröne HJ, Misselwitz B, Semmler W, Kiessling F. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005;40:504-13. [PMID: 16024988 DOI: 10.1097/01.rli.0000162925.26703.3a] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 4.2] [Reference Citation Analysis]
34 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
35 Sugihara S, Suto Y, Kamba M, Ogawa T. Comparison of various techniques of iron oxide-enhanced breath-hold MR imaging of hepatocellular carcinoma. Clinical Imaging 2001;25:104-9. [DOI: 10.1016/s0899-7071(01)00252-2] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
36 Santoro L, Grazioli L, Filippone A, Grassedonio E, Belli G, Colagrande S. Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization? J Magn Reson Imaging 2009;30:1012-20. [DOI: 10.1002/jmri.21937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
37 Abdollah MR, Kalber T, Tolner B, Southern P, Bear JC, Robson M, Pedley RB, Parkin IP, Pankhurst QA, Mulholland P, Chester K. Prolonging the circulatory retention of SPIONs using dextran sulfate: in vivo tracking achieved by functionalisation with near-infrared dyes. Faraday Discuss 2014;175:41-58. [PMID: 25298115 DOI: 10.1039/c4fd00114a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
38 Moore A, Marecos E, Bogdanov A Jr, Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000;214:568-74. [PMID: 10671613 DOI: 10.1148/radiology.214.2.r00fe19568] [Cited by in Crossref: 267] [Cited by in F6Publishing: 229] [Article Influence: 12.1] [Reference Citation Analysis]